envarsus
chiesi farmaceutici s.p.a. - tacrolimus - graft rejection - immunosuppressants - prophylaxis of transplant rejection in adult kidney or liver allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
modigraf
astellas pharma europe b.v. - tacrolimus - graft rejection - immunosuppressants - prophylaxis of transplant rejection in adult and paediatric, kidney, liver or heart allograft recipients.treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult and paediatric patients.
rapamune solution
pfizer canada ulc - sirolimus - solution - 1mg - sirolimus 1mg - immunosuppressive agents
rapamune tablet
pfizer canada ulc - sirolimus - tablet - 1mg - sirolimus 1mg - immunosuppressive agents
myfortic tablet (enteric-coated)
novartis pharmaceuticals canada inc - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 180mg - mycophenolic acid (mycophenolate sodium) 180mg - immunosuppressive agents
myfortic tablet (enteric-coated)
novartis pharmaceuticals canada inc - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 360mg - mycophenolic acid (mycophenolate sodium) 360mg - immunosuppressive agents
rapamune tablet
pfizer canada ulc - sirolimus - tablet - 2mg - sirolimus 2mg - immunosuppressive agents
rapamune tablet
pfizer canada ulc - sirolimus - tablet - 5mg - sirolimus 5mg - immunosuppressive agents
apo-mycophenolic acid tablet (enteric-coated)
apotex inc - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 180mg - mycophenolic acid (mycophenolate sodium) 180mg - immunosuppressive agents
apo-mycophenolic acid tablet (enteric-coated)
apotex inc - mycophenolic acid (mycophenolate sodium) - tablet (enteric-coated) - 360mg - mycophenolic acid (mycophenolate sodium) 360mg - immunosuppressive agents